Pregabalin Capsule
Product Images NDC 71205-298

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71205-298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-298-60 (Pregabalin 75mg 1000)

This is a description of a medication called Pregabalin 75mg, which comes in a bottle containing 60 capsules. The capsules are red and white and are imprinted with "LA" on top and "43" on the body, filled with white/off-white granular powder. The lot number is 00000 and the expiration date is 00/00/00. It's manufactured by Laurus Labs Limited in India and packaged by Proficient Rx LP. It's recommended to dispense the accompanying Medication Guide to each patient. The medication must be stored at a temperature between 20°-25°C (68°-77°F) and kept out of the reach of children.*

FDA Label Image

Pregabalinchemistrystructure (Pregabalin Chem Structure)

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

FDA Label Image

Pregabalinfig1 (Pregabalin Fig 01)

The text seems to be showing statistical data on the percent of patients who improved, as well as the percent improvement in pain from baseline. However, the format of the text is not clear and there are some non-English characters present. Therefore, it is difficult to generate a useful description.*

FDA Label Image

Pregabalinfig2 (Pregabalin Fig 02)

FDA Label Image

Pregabalinfig3 (Pregabalin Fig 03)

This appears to be a chart showing the percentage of patients who improved with different medications and dosages. The medications listed are Pregatalin and Pregabain, with various dosages and frequencies. There is also a mention of Flaosbo, but it is unclear what this refers to. The chart also includes a timeline or duration of treatment (20 days, 2 months, etc.) and a percent improvement in pain from a baseline measurement.*

FDA Label Image

Pregabalinfig4 (Pregabalin Fig 04)

FDA Label Image

Pregabalinfig5 (Pregabalin Fig 05)

FDA Label Image

Pregabalinfig6 (Pregabalin Fig 06)

FDA Label Image

Pregabalinfig7 (Pregabalin Fig 07)

FDA Label Image

Pregabalinfig8 (Pregabalin Fig 08)

FDA Label Image

Pregabalinfig9 (Pregabalin Fig 09)

FDA Label Image

Pregabalinfig10 (Pregabalin Fig 10)

The text provided is not clear and readable. Therefore, the description cannot be generated.*

FDA Label Image

Pregabalinfig11 (Pregabalin Fig 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.